摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(tetrahydro-2h-pyran-3-yl)piperazin | 914654-80-1

中文名称
——
中文别名
——
英文名称
(tetrahydro-2h-pyran-3-yl)piperazin
英文别名
1-(tetrahydro-pyran-3-yl)piperazine;1-(tetrahydro-2H-pyran-3-yl)Piperazine;1-(oxan-3-yl)piperazine
(tetrahydro-2h-pyran-3-yl)piperazin化学式
CAS
914654-80-1
化学式
C9H18N2O
mdl
——
分子量
170.255
InChiKey
NECAOEAZNSQZNA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    24.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Quinoline derivatives as neurokinin receptor antagonists
    申请人:Carling William Robert
    公开号:US20090054440A1
    公开(公告)日:2009-02-26
    The present invention relates to substituted quinoline hydrazides of Formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , X, Y and Z are defined herein, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors. These compounds can thus be used in methods of treatment to suppress and treat such disorders.
    本发明涉及式(I)所示的取代喹啉:其中R1、R2、R3、R4、R5、X、Y和Z在此定义,包含它们的药物组合物及其在治疗由神经激肽-2和/或神经激肽-3 (NK-3)受体介导的疾病中的用途。因此,这些化合物可用于治疗方法,以抑制和治疗这些疾病。
  • AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
    申请人:Beijing Adamadle Biotechnology Limited Liability Company
    公开号:EP3640248A1
    公开(公告)日:2020-04-22
    The present invention relates to an aminopyrimidine compound, a preparation method therefor and use thereof. The aminopyrimidine compound has the structure as shown in formula I: the compound is an inhibitor of an epidermal growth factor receptor (EGFR) kinase. The present invention also relates to a pharmaceutical composition containing the compounds, a method for preparing same and the use of same in preparation of anti-tumor drugs.
    本发明涉及一种氨基嘧啶化合物、其制备方法及其用途。氨基嘧啶化合物的结构如式 I 所示: 该化合物是表皮生长因子受体(EGFR)激酶的抑制剂。本发明还涉及一种含有上述化合物的药物组合物、其制备方法和在制备抗肿瘤药物中的用途。
  • ACTIVE LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMATION METHOD, MASK BLANK WITH RESIST FILM, METHOD FOR MANUFACTURING PHOTOMASK, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
    申请人:Fujifilm Corporation
    公开号:EP3731016A1
    公开(公告)日:2020-10-28
    The present invention provides an actinic ray-sensitive or radiation-sensitive resin composition that can provide a resist film with excellent sensitivity and a pattern with excellent LER performance, and can suppress pattern collapse during pattern formation. In addition, the present invention also provides a resist film, a pattern forming method, a mask blank with a resist film, a method for producing a photomask, and a method for manufacturing an electronic device, each using the actinic ray-sensitive or radiation-sensitive resin composition. The actinic ray-sensitive or radiation-sensitive resin composition of an embodiment of the present invention includes a resin X having a repeating unit A represented by General Formula (I), a repeating unit B having an acid-decomposable group, and a repeating unit C selected from a repeating unit c1 represented by General Formula (II) and the like; a compound Y which is a basic compound or ammonium salt compound whose basicity is reduced upon irradiation with actinic rays or radiation; and a photoacid generator Z which is a compound other than the compound Y.
    本发明提供了一种感光树脂或辐射敏感树脂组合物,该组合物可提供感光度极佳的抗蚀剂薄膜和 LER 性能极佳的图案,并可在图案形成过程中抑制图案塌陷。此外,本发明还提供了一种光刻胶膜、一种图案形成方法、一种带有光刻胶膜的掩膜坯、一种光掩膜的生产方法和一种电子设备的制造方法,每种方法都使用了该感光或辐射敏感树脂组合物。本发明一个实施例的感光或辐射敏感树脂组合物包括树脂 X,其具有通式(I)表示的重复单元 A、具有可酸化基团的重复单元 B 和选自通式(II)表示的重复单元 c1 及类似物的重复单元 C;化合物 Y,其为碱性化合物或盐化合物,其碱性在光射线或辐射照射时降低;以及光酸发生器 Z,其为化合物 Y 以外的化合物。
  • Aminopyrimidine compound, preparation method therefor and use thereof
    申请人:BEIJING ADAMADLE BIOTECHNOLOGY LIMITED LIABILITY COMPANY
    公开号:US11352352B2
    公开(公告)日:2022-06-07
    The present invention relates to an aminopyrimidine compound, a preparation method therefor and use thereof. The aminopyrimidine compound has the structure as shown in formula I: the compound is an inhibitor of an epidermal growth factor receptor (EGFR) kinase. The present invention also relates to a pharmaceutical composition containing the compounds, a method for preparing same and the use of same in preparation of anti-tumor drugs.
    本发明涉及一种氨基嘧啶化合物、其制备方法及其用途。氨基嘧啶化合物的结构如式 I 所示: 该化合物是表皮生长因子受体(EGFR)激酶的抑制剂。本发明还涉及一种含有上述化合物的药物组合物、制备方法以及在制备抗肿瘤药物中的应用。
查看更多